Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the monkey pox treatment market grown over the years?

The market for monkey pox treatment has expanded swiftly in the past few years. The market’s estimated worth, which sat at $0.09 billion in 2024, is predicted to rise to $0.1 billion in 2025, showcasing a compound annual growth rate (CAGR) of 13.6%. Factors contributing to such growth in the previous years include outbreaks in areas where the disease is endemic, increased awareness about zoonotic transmission, legacies from smallpox eradication, public health measures, and the emergence of human cases.

What Is the forecasted market size and growth rate for the monkey pox treatment market?

Anticipations for the monkey pox treatment market predict a swift expansion in the coming years, with an estimated worth of $0.17 billion in 2029, reflecting a Compound Annual Growth Rate (CAGR) of 13.3%. This development during the forecast span is ascribed to factors such as globalization and increased travel, governmental assistance and funding, investment in biotechnology and pharmaceuticals, public health monitoring, and regulatory accreditations. Significant trends during this period are anticipated to comprise the progress of antiviral drugs, utilization of smallpox vaccines, monoclonal antibodies, combination treatments, and research on long-term immunity.

Get your monkey pox treatment market report here!

https://www.thebusinessresearchcompany.com/report/monkey-pox-treatment-global-market-report

What are the major factors driving growth in the monkey pox treatment market?

The growth of the monkeypox treatment market is being driven forward by the escalating incidence of zoonotic infections. Zoonotic infections, diseases transmitted from animals to humans through direct contact or indirectly from contaminated environments or vectors, are becoming more prevalent. The risks of these infections are amplified by heightened interaction between humans and animals, creating more opportunities for contact. Furthermore, climate change exacerbates the problem by broadening the geographical range of disease vectors and spreading pathogens to previously unaffected regions. Treatments for monkeypox aim to control this type of zoonotic infection by targeting the virus and alleviating symptoms in both humans and potentially affected animals. A report from August 2024 by the UK Health Security Agency, a governmental organization, showed that there were 3,732 confirmed monkeypox cases in the UK, up from 3753 cases in 2023, an increase of 21 cases. Therefore, the rising incidence of zoonotic infections fuels the monkeypox treatment market.

What key areas define the segmentation of the global monkey pox treatment Market?

The monkey pox treatment market covered in this report is segmented –

1) By Treatment Type: Prophylactic Vaccines, Therapeutics

2) By Dosage Forms: Solid, Liquid, Semi Solid

3) By Route Of Administration: Oral, Topical, Parenteral

4) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies

Subsegments:

1) By Prophylactic Vaccines: Vaccinia-Based Vaccines, Modified Vaccinia Ankara (MVA) Vaccines, Other Vaccines (Recombinant Vaccines)

2) By Therapeutics: Antiviral Agents (Tecovirimat, Brincidofovir), Immune Modulators, Supportive Care Treatments

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18818&type=smp

What are the top market players propelling the growth of the monkey pox treatment industry?

Major companies operating in the monkey pox treatment market are Roche Holding AG, Merck & Co. Inc., Sanofi S.A., Gilead Sciences Inc., BioNTech SE, Moderna Inc., Quest Diagnostics Incorporated, Novavax Inc., Laboratory Corporation of America Holdings, Emergent BioSolutions Inc., Bavarian Nordic A/S, Aegis Sciences Corporation, Daan Gene Co. Ltd., Sansure Biotech Inc., SIGA Technologies Inc., Elabscience Biotechnology Inc., Mayo Clinic Laboratories, Tonix Pharmaceuticals Holding Corp., Altona Diagnostics GmbH, Lansion Biotechnology Co. Ltd., Goldsite Diagnostics Inc., Chimerix Inc., Emcure Pharmaceuticals Ltd., VBI Vaccines Inc

What emerging trends are influencing the growth of the monkey pox treatment market?

Top firms in the monkeypox treatment market are increasingly concentrating on technologies for remote monitoring and teletherapy like virtual care, with the aim of improving accessibility, patient management, and overall results of treatments. Through these virtual care solutions, patients who are at risk or already infected can receive remote medical check-ups, evaluations of symptoms, and advice on management tactics, thus increasing access to care and reducing the necessity for face-to-face appointments. For instance, Folx Health, a US healthcare firm, launched Monkeypox Care in August 2022. This service provides virtual primary health care to those who are either prone to monkeypox or already infected. It offers an all-inclusive strategy including education, counseling, symptom assessment, and referrals. This initiative aims to reach those in areas with limited healthcare access, ensuring that everyone, regardless of their location, has access to high-quality information and reference services.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18818

What regions are dominating the monkey pox treatment market growth?

North America was the largest region in the monkey pox treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the monkey pox treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Invasive Fungal Infections Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/invasive-fungal-infections-global-market-report

Infection Prevention Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/infection-prevention-global-market-report

Infection Control Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/infection-control-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: